Navigation Links
Source Precision Medicine, Inc. d/b/a Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011
Date:3/21/2011

WELLESLEY HILLS, Mass., March 21, 2011 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Source Precision Medicine, Inc. d/b/a/ Source MDx ("Source MDx") announced that the foundational patents of Source MDx will be offered for sale on April 29, 2011.

Source MDx holds a broad-based, array of patents that cover technical aspects of RNA transcript measurement, concepts surrounding normal ranges in healthy human subjects ("normals") and statistical methods generating multi-gene models for the discrimination of normals versus disease.  Key patents comprise the foundation of Source MDx's intellectual property portfolio.  These include:

A.  Systems and Methods for Characterizing a Biological Condition or Agent using Precision Gene Expression (#6,692,916 issued 02.17.04)

B.  Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles (#6,940,439 issued 11.01.05)

C.  Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles (#6,964,850 pending)

Persons interested in bidding must sign a Confidentiality Disclosure Agreement ("CDA") obtained from Finn's office – jffinnjr@finnwarnkegayton or 781-27-8840.  They will then receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm Finn, Warnke & Gayton LLP of Wellesley Hills, Massachusetts (www.finnwarnkegayton.com).  He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as Assignee for the Benefit of Creditors and Liquidating Agent for corporations.  He has been involved in a number of loan workouts and bankruptcy cases for thirty-six (36) years.  His most recent Assignments for the Benefit of Creditors in the biotech field include Spherics, Inc., ActivBioics, Inc. Prospect Therapeutics, Inc. and Epix Pharmaceuticals, Inc.

For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840 or jffinnjr@finnwarnkegatyon.com


'/>"/>
SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland
2. MPR Launches Patient Advisor—A Drug and Health Information Resource for Consumers From the Trusted Source Healthcare Practitioners Rely On
3. Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP
4. Global Sources extends its contract with AsiaWorld-Expo to host China Sourcing Fairs in Hong Kong through 2014
5. American Scientific Resources Announces New Distributor HospiServices Placing Kidz-Med VeraTemp in Middle Eastern and African Pharmacies
6. American Scientific Resources Rebrands Non-Contact Thermometer for Mass Market Consumer Appeal
7. Merz Launches New Online Resource for Patients with Focal Dystonias
8. BioMedix™ Now Exclusive Industry Distributor of the APMA Coding Resource Center
9. New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure
10. American Scientific Resources, Inc. Announces S-1 Registration Statement Effective; Commences Public Reporting Requirements
11. FDA Launches Website To Help Regulated Industries Save Time, Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... N.Y. , Dec. 6, 2016  Licenders is bringing their ... This new location in Park Slope at 203 13 th ... Brooklyn clientele. "Our goal is to ... treatment plans are designed to get children right back to class ... are 100% all natural and safe for the whole family," Licenders ...
(Date:12/6/2016)... 2016  "Blood Tests replace Surgical Biopsies. Single ... The Diagnostic, Monitoring and Screening Test opportunities are ... occurring using in vitro blood testing to identify ... backing, has announced a single blood test to ... than the market. New technology that definitively identifies ...
(Date:12/6/2016)... 6, 2016 Diabetes & Obesity Drug Development ... obesity disease cluster is currently dominated by therapeutics indicated ... diabetes mellitus (T2DM), and the majority of the pipeline, ... is attributable to these indications. While products indicated for ... there are a large number of these products in ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... ... AlignLife clinics nationwide are giving back to their communities by collecting toys ... gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread the joy ... In exchange for generous donations, customers will receive a gift in return. Anyone ...
(Date:12/7/2016)... Honolulu, HI (PRWEB) , ... December 07, 2016 ... ... Dermatology is proud to announce that its fully redesigned website, which launched October ... well as a sleek responsive design and easy-to-navigate layout. Visitors and patients can ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live From ... the year’s best in pioneering, inventive, and ultimately successful projects undertaken by the ...
(Date:12/7/2016)... AZ (PRWEB) , ... December ... ... ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus for ... WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment modalities ...
(Date:12/7/2016)... ... 2016 , ... “Walking With God: Inspirational Lessons from My Life's Journey”: ... be aware of God's direction in their lives. “Walking With God: Inspirational Lessons from ... active church leader. , Sanford says, “I enjoy sharing the true stories ...
Breaking Medicine News(10 mins):